MENU
ELEV
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Elevation Oncology (ELEV) Earnings Date & Reports

Elevation Oncology Inc is an oncology company focused on the development of selective cancer therapies to treat patients across a range of solid tumors with unmet medical needs... Show more

A.I. Advisor
published Earnings

ELEV is expected to report earnings to fall 44.25% to -13 cents per share on November 06

Elevation Oncology ELEV Stock Earnings Reports
Q3'25
Est.
$-0.13
Q1'25
Missed
by $0.04
Q4'24
Beat
by $0.04
Q3'24
Missed
by $0.03
Q2'24
Beat
by $0.04
The last earnings report on May 14 showed earnings per share of -23 cents, missing the estimate of -20 cents. With 4.79M shares outstanding, the current market capitalization sits at 21.63M.
View a ticker or compare two or three
ELEV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ELEV showed earnings on May 14, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
101 Federal Street
Phone
+1 716 371-1125
Employees
29
Web
https://www.elevationoncology.com